Newly Diagnosed Multiple Myeloma is Associated with Hypercoagulability and High Risk of VTE The ROADMAP Study

Despina Fotiou; Grigoris Gerotziafas; Flora Zagouri; Theodoros Ν. Sergentanis; Κimon Stamatelopoulos; Θεοδώρα Ψαλτοπούλου; Efstathios Kastritis; Evangelos Terpos; Meletios A Dimopoulos

doi:10.1016/j.clml.2016.07.106

Related publications

Article2022

Treatment Resistance Risk in Patients with Newly Diagnosed Multiple Myeloma Is Associated with Blood Hypercoagulability: The ROADMAP-MM Study

Grigoris Gerotziafas, Despina Fotiou, Theodoros Ν. Sergentanis, Loula Papageorgiou, Jawed Fareed, Anna Falanga, Michèle Sabbah, Laurent Garderet, Evangelos Terpos, Ismaı̈l Elalamy, Patrick Van Dreden, Meletios A Dimopoulos

Article2011

Diffuse Pattern of Bone Marrow Involvement in MRI Is Associated with High Risk Cytogenetics and Poor Outcome in Newly Diagnosed, Symptomatic Patients with Multiple Myeloma,

Lia A. Moulopoulos, Efstathios Kastritis, Evangelos Terpos, Μαρία Γκοτζαμανίδου, Μαρία Ρούσσου, Ανδρέας Κουρέας, Magdalini Migkou, Maria Gavriatopoulou, Dimitra Gika, Vassilis Koutoulidis, Meletios A Dimopoulos

Article2015

Newly Diagnosed Multiple Myeloma Is Associated with Enhanced TF Pathway Activation, Thrombin Generation and Increased Concentration of Procoagulant Microparticles

Grigoris Gerotziafas, Flora Zagouri, Despina Fotiou, Theodoros Ν. Sergentanis, Κimon Stamatelopoulos, Θεοδώρα Ψαλτοπούλου, Efstathios Kastritis, Evangelos Terpos, Patrick Van Dreden, Aurélie Rousseau, Ilias Evmorfiadis, Ismaı̈l Elalamy, Annette K. Larsen, Meletios A Dimopoulos

Letter2011

Zoledronic acid for all patients with newly diagnosed multiple myeloma?

Evangelos Terpos, Meletios A Dimopoulos

Article2019

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Loula Papageorgiou, Despina Fotiou, Patrick Van Dreden, Laurent Garderet, Meletios A Dimopoulos, Ismaı̈l Elalamy, Mohamad Mohty, Grigoris Gerotziafas